A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung. (Q42224638)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 April 2014

Language	Label	Description	Also known as
English	A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.	scientific article published on 13 April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

0 references

systemic immune response

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

Vanessa Neuhaus

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Jessica A Chichester

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Thomas Ebensen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Katharina Schwarz

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Caitlin E Hartman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yoko Shoji

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Carlos A Guzmán

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Katherina Sewald

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

0 references

publication date

13 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

3216-3222

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Adjuvant Effects of Amorphous Silica and of Aluminium Hydroxide on IgE and IgG<sub>1</sub> Antibody Production in Different Inbred Mouse Strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Using plant cells as influenza vaccine substrates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Determinants of immunity to influenza infection in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

A plant-based system for rapid production of influenza vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The NKT cell ligand αgalactosylceramide suppresses allergic airway inflammation by induction of a Th1 response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Ex vivo testing of immune responses in precision-cut lung slices

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Characterization of airway and vascular responses in murine lungs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Induction of secretory immunity and memory at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Mucosal IgA responses in influenza virus infections; thoughts for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Resident Memory T Cells (TRM) Are Abundant in Human Lung: Diversity, Function, and Antigen Specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42224638&oldid=1566680587"